Clonidine





































































































Clonidine hydrochloride extended-release tablet computers are suggested for the treatment of interest deficit hyperactivity condition (ADHD) as monotherapy and as adjunctive therapy to stimulant medicines.





The efficacy of clonidine hydrochloride extended-release tablets in the therapy of ADHD is based upon 2 regulated trials (one monotherapy as well as one adjunctive to stimulant medication) in children as well as teenagers ages 6-17 who complied with DSM-IV criteria for ADHD hyperactive or consolidated hyperactive/inattentive subtypes [see Clinical Studies (14)] In the adjunctive research, clonidine hydrochloride extended-release tablets were provided to clients which had been on a secure program of either methylphenidate or amphetamine (or their derivatives) and also who had actually not attained an ideal feedback. The effectiveness of clonidine hydrochloride extended-release tablet computers for longer-term usage (greater than 5 weeks) has not been systematically examined in regulated tests.





A medical diagnosis of ADHD implies the existence of hyperactive-impulsive and/or neglectful symptoms that trigger problems as well as existed just before the age of 7 years. The signs and symptoms have to create clinically significant impairment, e. g. in social, academic, or work-related functioning, as well as be present in 2 or even more settings, e. g. college (or work) and at residence. The signs must not be much better made up by another mental problem. For the Inattentive Type, at the very least six of the complying with symptoms should have lingered for at the very least 6 months: lack of attention to details/careless mistakes; absence of sustained focus; bad listener; failure to comply with through on tasks; bad organization; avoids activities needing continual psychological effort; losses things; easily distracted; absent-minded. For the Hyperactive-Impulsive Type, a minimum of six of the complying with signs and symptoms must have persisted for a minimum of 6 months: fidgeting/squirming; leaving seat; unacceptable running/climbing; difficulty with quiet tasks; "on the move"; excessive talking; blurting responses; cannot wait turn; intrusive. The Combined Type needs both neglectful and hyperactive-impulsive criteria to be satisfied.

Clonidine HCL 0.2 mg Tablet. Clonidine HCL 0.2 mg. Clonidime.

Site Map:

Clonidine